The results from the loss- and gain-of-function experiments imply that TRIM25 exerts a constitutive suppressive effect on caspase-7 expression mainly through destabilization of caspase-7 mRNA and thereby contributes to the primary drug resistance of CRC cells. The gene discussed is TRIM25; the disease is colorectal carcinoma.